eWave Patch: This device is a wearable multi-channel ECG monitoring device for continuous cardiac rhythm tracking.
Study summary
This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Adult \>18 years old and able to consent
* Capable of using a smartphone app
* Willing to shave patch area if needed
Exclusion Criteria:
* Planning to undergo an MRI during the study period
* Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results
* Presence of pacemaker, ICD or other implanted electronic devices
* Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum)
* Pregnant or intending to become pregnant during the course of the study
Primary outcome measure(s)
Wear Duration — 7 Days Days of use until one of the following is reached: patch no longer adheres, signal loss, voluntary removal, or 7 days is achieved
Adverse Events — 7 Days Incidences of self-reported adverse events for the duration of the study
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.